handshake-istock-512549722-choreograph-
Choreograph / iStockphoto.com
22 February 2018Americas

The licensing landscape at Pieris

From its formation in 2001, Pieris has come a long way. Since 2009, it has entered into a number of licensing deals after other companies approached Pieris expressing a need for a new therapeutic.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
4 May 2017   AstraZeneca has entered into a collaboration with biotech company Pieris Pharmaceuticals to develop novel inhaled drugs that expand on Pieris’s Anticalin platform.

More on this story

Americas
4 May 2017   AstraZeneca has entered into a collaboration with biotech company Pieris Pharmaceuticals to develop novel inhaled drugs that expand on Pieris’s Anticalin platform.

More on this story

Americas
4 May 2017   AstraZeneca has entered into a collaboration with biotech company Pieris Pharmaceuticals to develop novel inhaled drugs that expand on Pieris’s Anticalin platform.